The interior of Vanderbilt's Medical Research Building III taken by Neil Brake of Vanderbilt UniversityNASHVILLE, Tenn.- Vanderbilt University Medical Center received a five-year, $1 million grant to establish a center dedicated to the study of proteins for drug discovery.
Announced Tuesday, the grant will establish the National Foundation for Cancer Research Center for Proteomics and Drug Action. Proteomics is the study of proteins and how they work, according to Vanderbilt University.
Dr. Lawrence Marnett will direct the center. Marnett is the director of the Vanderbilt Institute of Chemical Biology and the A.B. Hancock Jr. Memorial Laboratory for Cancer Research.
Other principal investigators at the center will be Dr. Richard Caprioli, Stanley Cohen Professor of Biochemistry and professor of pharmacology and chemistry; and Dr. Daniel Liebler, professor of biochemistry and pharmacology.
Liebler directs Vanderbilt's Proteomics Laboratory and the Jim Ayers Institute for Pre-Cancer Detection and Diagnosis at Vanderbilt-Ingram Cancer Center.
Caprioli directs Vanderbilt's Mass Spectrometry Research Center.
VUMC is one of 10 NFCR-funded "research discovery centers" focusing on understanding, diagnosing and treating cancer.
